Platelets, inflammation and anti-inflammatory drugs in ACS and CAD
作者： Karsten Schrör , Kurt Huber , None
DOI: 10.1160/TH15-08-0632
关键词:
摘要: In this theme issue, which is based on the annual meeting of European Platelet Academy (EPA) 2014 in Dresden, Germany (organiser: K. Schror), authors aimed to present and discuss newest developments an important topic, exciting also for its clinical relevance: The relationship between platelets, inflammation anti-inflammatory agents. following paragraphs representing subtopics we summarise recent knowledge.
thieme-connect.de参考文章(30)
E Reilly, U Slager, Platelet function testing. Western Journal of Medicine. ,vol. 128, pp. 49- 50 ,(1978)
Artur-Aron Weber, Collin Jacobs, Dan Meila, Stephanie Weber, Rainer Zotz, Rudiger Scharf, Malte Kelm, Bodo Strauer, Karsten Schror, No evidence for an influence of the human platelet antigen-1 polymorphism on the antiplatelet effects of glycoprotein IIb/IIIa inhibitors. Pharmacogenetics. ,vol. 12, pp. 581- 583 ,(2002) , 10.1097/00008571-200210000-00011
Gabriella Passacquale, Albert Ferro, Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation. British Journal of Clinical Pharmacology. ,vol. 72, pp. 604- 618 ,(2011) , 10.1111/J.1365-2125.2011.03906.X
K. Schrör, Why we should not skip aspirin in cardiovascular prevention Hämostaseologie. ,vol. 36, pp. 33- 43 ,(2016) , 10.5482/HAMO-14-10-0048
Ewa Placzkiewicz-Jankowska, Lukasz Zieliński, Wieslawa Tracz, Anetta Undas, Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin Thrombosis and Haemostasis. ,vol. 97, pp. 1056- 1058 ,(2007) , 10.1160/TH07-01-0047
Sanne Bøjet Larsen, Erik Lerkevang Grove, Anne-Mette Hvas, Steen Dalby Kristensen, Platelet turnover in stable coronary artery disease - influence of thrombopoietin and low-grade inflammation. PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0085566
Victor L. Serebruany, Charles C. Cummings, Alex I. Malinin, Steven R. Steinhubl, Paul A. Gurbel, Uniform platelet activation exists before coronary stent implantation despite aspirin therapy American Heart Journal. ,vol. 142, pp. 611- 616 ,(2001) , 10.1067/MHJ.2001.116478
Anetta Undas, Kathleen E. Brummel-Ziedins, Kenneth G. Mann, Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood. ,vol. 109, pp. 2285- 2292 ,(2007) , 10.1182/BLOOD-2006-01-010645
Steen Husted, Robert F. Storey, Robert A. Harrington, Håkan Emanuelsson, Christopher P. Cannon, Changes in Inflammatory Biomarkers in Patients Treated With Ticagrelor or Clopidogrel Clinical Cardiology. ,vol. 33, pp. 206- 212 ,(2010) , 10.1002/CLC.20732
Oscar Ö Braun, Matilda Johnell, Stefan James, John T Brandt, Joseph A Jakubowski, Kenneth J Winters, Lars Wallentin, David Erlinge, Agneta Siegbahn, None, Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease Thrombosis and Haemostasis. ,vol. 100, pp. 626- 633 ,(2008) , 10.1160/TH08-05-0313